Molecular genetic methods in diagnosis and direct characterization of acute bacterial central nervous system infections

APMIS

Volumn 112, Issue 11-12, 2004, Pages 753-770

  Taha, Muhamed Kheir ^a   Olcén, Per ^b  

^a INSTITUT PASTEUR   (France)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute bacterial infection; Bacteria; Epidemiological marker; Meningitis; Molecular diagnosis; PCR

Indexed keywords

BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CENTRAL NERVOUS SYSTEM INFECTION; ESCHERICHIA COLI K 12; HAEMOPHILUS INFLUENZAE; LISTERIA MONOCYTOGENES; MENINGITIS; MOLECULAR GENETICS; NEISSERIA MENINGITIDIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEROLOGY; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE;

ACUTE DISEASE; BACTERIAL INFECTIONS; BACTERIAL TYPING TECHNIQUES; BACTERIOLOGICAL TECHNIQUES; CENTRAL NERVOUS SYSTEM INFECTIONS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HUMANS; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; RIBOTYPING;

EID: 12744279863     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2004.apm11211-1204.x     Document Type: Review

References (171)

1. Reese TS, Karnovsky MJ. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 1967;34:207-17.
2. Gray F, Alonso JM. Bacterial Infections. In: Lantos PL, editor. Greenfield's Neuropathology. 7th ed. London: Arnold Publishers, 2002:151-89.
3. Quagliarello V, Scheld WM. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med 1992;327:864-72.
4. Saez-Llorens XJ, Umana MA, Odio CM, Mc Cracken GH Jr, Nelson JD. Brain abscess in infants and children. Pediatr Infect Dis J 1989;8:449-58.
5. Strong AJ, Ingham HR. Brain abscess. Br J Hosp Med 1983;30:396, 398, 400 passim.
6. Miorner H, Sjobring U, Nayak P, Chandramuki A. Diagnosis of tuberculous meningitis: a comparative analysis of 3 immunoassays, an immune complex assay and the polymerase chain reaction. Tuber Lung Dis 1995;76:381-6.
7. Monteyne P, Sindic CJ. The diagnosis of tuberculous meningitis. Acta Neurol Belg 1995;95:80-7.
8. Jorbeck HJ, Gustafsson PM, Lind HC, Stiernstedt GT. Tick-borne Borrelia-meningitis in children. An outbreak in the Kalmar area during the summer of 1984. Acta Paediatr Scand 1987;76:228-33.
9. Chesky M, Scalco R, Failace L, Read S, Jobim LF. Polymerase chain reaction for the laboratory diagnosis of aseptic meningitis and encephalitis. Arq Neuropsiquiatr 2000;58:836-42.
10. Spanos A, Harrell FE Jr, Durack DT. Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations. JAMA 1989;262:2700-7.
11. Vandekerkove M, Bradstreet P, Faucon R, Benech S. [Transport medium for meningococci]. Ann Inst Pasteur (Paris) 1967;113:260-3.
12. Guibourdenche M, Riou JY. Méthodes de laboratoire: Neisseria et Branhamella. Commission des Laboratoires de Référence et d'Expertise. Paris: Institut Pasteur, 1992.
13. Ajello GW, Feeley JC, Hayes PS, Reingold AL, Bolan G, Broome CV, et al. Trans-isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. J Clin Microbiol 1984;20:55-8.
14. Wasas AD, Huebner RE, Klugman KP. Use of Dorset egg medium for maintenance and transport of Neisseria meningitidis and Haemophilus influenzae type b. J Clin Microbiol 1999;37:2045-6.
15. Daly JK, Seskin KC, Pezzlo M. Processing and interpretation of cerebrospinal fluid. In: Isenberg HD, editor. Clinical microbiology procedures handbook. Washington, DC: American Society for Microbiology, 1992:1.9.1-1.9.7.
16. Ray CG, Smith BL, Wasilauskas L, Zabransky R. In: Smith JA, editor. Cumitech 14A, Laboratory diagnosis of central nervous system infections. Washington, DC: American Society for Microbiology, 1993.
17. Arvidson S, Dornbusch K, Ericsson H. Interpretation of the agar diffusion method for bacterial susceptibility testing. J Antimicrob Chemother 1981;7:5-14.
18. Ericsson HM, Sherris JC. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand [B] Microbiol Immunol 1971;217:Suppl 217:1-90.
19. Abdillahi H, Poolman JT. Definition of meningococcal class 1 OMP subtyping antigens by monoclonal antibodies. FEMS Microbiol Immunol 1988;1:139-44.
20. Abdillahi H, Poolman JT. Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA. J Med Microbiol 1988;26:177-80.
21. Tsai CM, Mocca LF, Frasch CE. Immunotype epitopes of Neisseria meningitidis lipooligosaccharide types 1 through 8. Infect Immun 1987;55:1652-6.
22. Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. Jama 1993;269:221-6.
23. Wenger JD. Impact of Haemophilus influenzae type b vaccines on the epidemiology of bacterial meningitis. Infect Agents Dis 1993;2:324-32.
24. Scott JA, Obiero J, Hall AJ, Marsh K. Validation of immunoglobulin G enzyme-linked immunosorbent assay for antibodies to pneumococcal surface adhesin A in the diagnosis of pneumococcal pneumonia among adults in Kenya. J Infect Dis 2002;186:220-6.
25. Hausdorff WP. Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution. Eur J Pediatr 2002;161 Suppl 2:S135-9.
26. Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000;30:100-21.
27. Vereanu A, Mihalcu F, Stanescu C, Dorobat O, Burcea H, State D. Diagnosis of pneumococcal meningitis by coagglutination method. Arch Roum Pathol Exp Microbiol 1989;48:7-12.
28. Ørskov F, Orskov I. Escherichia coli O:H serotypes isolated from human blood. Prevalence of the K1 antigen with technical details of O and H antigenic determination. Acta Pathol Microbiol Scand Suppl 1975;83:595-600.
29. Devine DA, Roberts AP, Rowe B. Simple technique for detecting K1 antigen of Escherichia coli. J Clin Pathol 1990;43:76-8.
30. Borchardt SM, Foxman B, Chaffin DO, Rubens CE, Tallman PA, Manning SD, et al. Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing. J Clin Microbiol 2004;42:146-50.
31. Rowe B, Gross RJ, Allen HA. Citrobacter koseri. II. Serological and biochemical examination of Citrobacter koseri strains from clinical specimens. J Hyg (Lond) 1975;75:129-34.
32. Mieszala M, Lipinski T, Kocharova NA, Zatonsky GV, Katzenellenbogen E, Shashkov AS, et al. The identity of the O-specific polysaccharide structure of Citrobacter strains from serogroups O2, O20 and O25 and immunochemical characterisation of C. youngae PCM 1507 (O2a, 1b) and related strains. FEMS Immunol Med Microbiol 2003;36:71-6.
33. Simoons-Smit AM, Verweij-Van Vught AM, Kanis IY, MacLaren DM. Biochemical and serological investigations on clinical isolates of klebsiella. J Hyg (Lond) 1985;95:265-76.
34. Notermans S, Chakraborty T, Leimeister-Wachter M, Dufrenne J, Heuvelman KJ, Maas H, et al. Specific gene probe for detection of biotyped and serotyped Listeria strains. Appl Environ Microbiol 1989;55:902-6.
35. Cartwright KA. Early management of meningococcal disease. Infect Dis Clin North Am 1999;13:661-84, viii.
36. Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics 2001;108:1169-74.
37. Dunbar SA, Eason RA, Musher DM, Clarridge JE 3rd. Microscopic examination and broth culture of cerebrospinal fluid in diagnosis of meningitis. J Clin Microbiol 1998;36:1617-20.
38. Cartwright KA, Reilly S, White D, Stuart J. Early treatment with parenteral penicillin in meningococcal disease. BMJ 1992;305:143-7.
39. Aguiar-Nogueira J, Lecour H, Luz-Dias M. Use of a latex agglutination test in rapid diagnosis of acute meningitis. Enferm Infecc Microbiol Clin 1989;7:186-8.
40. Danielsson D, Olcén P. Rapid serotyping of groups A, B, and C meningococci by rocket-line immunoelectrophoresis and co-agglutination. J Clin Pathol 1979;32:136-42.
41. Olcén P. Serological methods for rapid diagnosis of Haemophilus Influenzae, Neisseria meningitidis and Streptococcus pneumoniae in cerebrospinal fluid: a comparison of Co-agglutination, immunofluorescence and immunoelectroosmophoresis. Scand J Infect Dis 1978;10:283-9.
42. Hoff GE, Høby N. [Rapid etiological diagnosis in bacterial meningitis]. Ugeskr Laeger 1975;137:1713-5.
43. Ballard TL, Roe MH, Wheeler RC, Todd JK, Glode MP. Comparison of three latex agglutination kits and counterimmunoelectrophoresis for the detection of bacterial antigens in a pediatric population. Pediatr Infect Dis J 1987;6:630-4.
44. Hoff GE, Høby N. Cross-reactions between Neisseria meningitidis and twenty-seven other bacterial species. Acta Pathol Microbiol Scandinavica Section B, Microbiology 1978;86:87-92.
45. Salih MA, Ahmed HS, Hofvander Y, Danielsson D, Olcén P. Rapid diagnosis of bacterial meningitis by an enzyme immunoassay of cerebrospinal fluid. Epidemiol Infect 1989;103:301-10.
46. Gray SJ, Sobanski MA, Kaczmarski EB, Guiver M, Marsh WJ, Borrow R, et al. Ultrasound-enhanced latex immunoagglutination and PCR as complementary methods for non-culture-based confirmation of meningococcal disease. J Clin Microbiol 1999;37:1797-801.
47. Porritt RJ, Mercer JL, Munro R. Ultrasound-enhanced latex immunoagglutination test (USELAT) for detection of capsular polysaccharide antigen of Neisseria meningitidis from CSF and plasma. Pathology 2003;35:61-4.
48. Sobanski MA, Barnes RA, Gray SJ, Carr AD, Kaczmarski EB, O'Rourke A, et al. Measurement of serum antigen concentration by ultrasound-enhanced immunoassay and correlation with clinical outcome in meningococcal disease. Eur J Clin Microbiol Infect Dis 2000;19:260-6.
49. Kaczmarski EB, Cartwright KA. Control of meningococcal disease: guidance for microbiologists: CCDC. Consultant in Communicable Disease Control, England. Commun Dis Rep CDR Rev 1995;5:R196-8.
50. Olcén P, Eeg-Olofsson O, Fryden A, Kernell A, Ansehn S. Benign meningococcemia in childhood. A report of five cases with clinical and diagnostic remarks. Scand J Infect Dis 1978;10:107-11.
51. Feil EJ, Holmes EC, Bessen DE, Chan MS, Day NP, Enright MC, et al. Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci USA 2001;98:182-7.
52. Voll MJ, Goodgal SH. Recombination during transformation in Hemophilus influenzae. Proc Natl Acad Sci USA 1961;47:505-12.
53. Ninet B, Bannerman E, Bille J. Assessment of the Accuprobe Listeria monocytogenes culture identification reagent kit for rapid colony confirmation and its application in various enrichment broths. Appl Environ Microbiol 1992;58:4055-9.
54. Harmsen D, Singer C, Rothganger J, Tønjum T, de Hoog GS, Shah H, et al. Diagnostics of Neisseriaceae and Moraxellaceae by ribosomal DNA sequencing: ribosomal differentiation of medical microorganisms. J Clin Microbiol 2001;39:936-42.
55. Greisen K, Loeffelholz M, Purohit A, Leong D. PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid. J Clin Microbiol 1994;32:335-51.
56. Spratt BG, Maiden MC. Bacterial population genetics, evolution and epidemiology. Philos Trans R Soc Lond B Biol Sci 1999;354:701-10.
57. Tenover FC. DNA hybridization techniques and their application to the diagnosis of infectious diseases. Infect Dis Clin North Am 1993;7:171-81.
58. Ley BE, Linton CJ, Bennett DM, Jalal H, Foot AB, Millar MR. Detection of bacteraemia in patients with fever and neutropenia using 16S rRNA gene amplification by polymerase chain reaction. Eur J Clin Microbiol Infect Dis 1998;17:247-53.
59. Xu J, Millar BC, Moore JE, Murphy K, Webb H, Fox AJ, et al. Employment of broad-range 16S rRNA PCR to detect aetiological agents of infection from clinical specimens in patients with acute meningitis-rapid separation of 16S rRNA PCR amplicons without the need for cloning. J Appl Microbiol 2003;94:197-206.
60. Rådstrøm P, Bäckman A, Qian N, Kragsbjerg P, Pahlson C, Olcén P. Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and streptococci using a seminested PCR strategy. J Clin Microbiol 1994;32:2738-44.
61. Dicuonzo G, Lorino G, Lilli D, Rivanera D, Guarino P, Angeletti S, et al. Use of oligoprobes on amplified DNA in the diagnosis of bacterial meningitis. Eur J Clin Microbiol Infect Dis 1999;18:352-7.
62. Bäckman A, Lantz P, Rådstrøm P, Olcén P. Evaluation of an extended diagnostic PCR assay for detection and verification of the common causes of bacterial meningitis in CSF and other biological samples. Mol Cell Probes 1999;13:49-60.
63. Corless CE, Guiver M, Borrow R, Edwards-Jones V, Kaczmarski EB, Fox AJ. Contamination and sensitivity issues with a real-time universal 16S rRNA PCR. J Clin Microbiol 2000;38:1747-52.
64. Corless CE, Guiver M, Borrow R, Edwards-Jones V, Fox AJ, Kaczmarski EB. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 2001;39:1553-8.
65. Taha MK, Parent Du Chatelet I, Schlumberger M, Sanou I, Djibo S, de Chabalier F, et al. Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. J Clin Microbiol 2002;40:1083-4.
66. Balganesh M, Lalitha MK, Nathaniel R. Rapid diagnosis of acute pyogenic meningitis by a combined PCR dot-blot assay. Mol Cell Probes 2000;14:61-9.
67. Ni H, Knight AI, Cartwright K, Palmer WH, McFadden J. Polymerase chain reaction for diagnosis of meningococcal meningitis. Lancet 1992;340:1432-4.
68. Porritt RJ, Mercer JL, Munro R. Detection and serogroup determination of Neisseria meningitidis in CSF by polymerase chain reaction (PCR). Pathology 2000;32:42-5.
69. Tzanakaki G, Tsolia M, Vlachou V, Theodoridou M, Pangalis A, Foustoukou M, et al. Evaluation of non-culture diagnosis of invasive meningococcal disease by polymerase chain reaction (PCR). FEMS Immunol Med Microbiol 2003;39:31-6.
70. Borrow R, Guiver M, Sadler F, Kaczmarski EB, Fox AJ. False positive diagnosis of meningococcal infection by the IS1106 PCR ELISA. FEMS Microbiol Lett 1998;162:215-8.
71. Kristiansen BE, Ask E, Jenkins A, Fermér C, Radstrom P, Skold O. Rapid diagnosis of meningococcal meningitis by polymerase chain reaction. Lancet 1991;337:1568-9.
72. Mölling P, Jacobsson S, Bäckman A, Olcén P. Direct and rapid identification and genogrouping of meningococci and porA amplification by LightCycler PCR. J Clin Microbiol 2002;40:4531-5.
73. Urwin R, Kaczmarski EB, Guiver M, Fox AJ, Maiden MC. Amplification of the meningococcal porB gene for non-culture serotype characterization. Epidemiol Infect 1998;120:257-62.
74. Guiver M, Borrow R, Marsh J, Gray SJ, Kaczmarski EB, Howells D, et al. Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA. FEMS Immunol Med Microbiol 2000;28:173-9.
75. Kaczmarski EB, Ragunathan PL, Marsh J, Gray SJ, Guiver M. Creating a national service for the diagnosis of meningococcal disease by polymerase chain reaction. Commun Dis Public Health 1998;1:54-6.
76. Taha MK. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J Clin Microbiol 2000;38:855-7.
77. van Haeften R, Palladino S, Kay I, Keil T, Heath C, Waterer GW. A quantitative LightCycler PCR to detect Streptococcus pneumoniae in blood and CSF. Diagn Microbiol Infect Dis 2003;47:407-14.
78. Dagan R, Shriker O, Hazan I, Leibovitz E, Greenberg D, Schlaeffer F, et al. Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR. J Clin Microbiol 1998;36:669-73.
79. Kroll JS, Loynds BM, Moxon ER. The Haemophilus influenzae capsulation gene cluster: a compound transposon. Mol Microbiol 1991;5:1549-60.
80. Hassan-King M, Adegbola R, Baldeh I, Mulholland K, Omosigho C, Oparaugo A, et al. A polymerase chain reaction for the diagnosis of Haemophilus influenzae type b disease in children and its evaluation during a vaccine trial. Pediatr Infect Dis J 1998;17:309-12.
81. Jaton K, Sahli R, Bille J. Development of polymerase chain reaction assays for detection of Listeria monocytogenes in clinical cerebrospinal fluid samples. J Clin Microbiol 1992;30:1931-6.
82. Lunge VR, Miller BJ, Livak KJ, Batt CA. Factors affecting the performance of 5' nuclease PCR assays for Listeria monocytogenes detection. J Microbiol Methods 2002;51:361-8.
83. Scheu P, Gasch A, Berghof K. Rapid detection of Listeria monocytogenes by PCR-ELISA. Lett Appl Microbiol 1999;29:416-20.
84. Bassler HA, Flood SJ, Livak KJ, Marmaro J, Knorr R, Batt CA. Use of a fluorogenic probe in a PCR-based assay for the detection of Listeria monocytogenes. Appl Environ Microbiol 1995;61:3724-8.
85. Kearns AM, Seiders PR, Wheeler J, Freeman R, Steward M. Rapid detection of methicillin-resistant staphylococci by multiplex PCR. J Hosp Infect 1999;43:33-7.
86. Dore N, Bennett D, Kaliszer M, Cafferkey M, Smyth CJ. Molecular epidemiology of group B streptococci in Ireland: associations between serotype, invasive status and presence of genes encoding putative virulence factors. Epidemiol Infect 2003;131:823-33.
87. Ragunathan L, Ramsay M, Borrow R, Guiver M, Gray S, Kaczmarski EB. Clinical features, laboratory findings and management of meningococcal meningitis in England and Wales: report of a 1997 survey. Meningococcal meningitis: 1997 survey report. J Infect 2000;40:74-9.
88. Millar BC, Xu J, Moore JE. Risk assessment models and contamination management: implications for broad-range ribosomal DNA PCR as a diagnostic tool in medical bacteriology. J Clin Microbiol 2002;40:1575-80.
89. Vázquez JA, Arreaza L, Block C, Ehrhard I, Gray SJ, Heuberger S, et al. Interlaboratory comparison of agar dilution and Etest methods for determining the MICs of antibiotics used in management of Neisseria meningitidis infections. Antimicrob Agents Chemother 2003;47:3430-4.
90. Tenover FC, Huang MB, Rasheed JK, Persing DH. Development of PCR assays to detect ampicillin resistance genes in cerebrospinal fluid samples containing Haemophilus influenzae. J Clin Microbiol 1994;32:2729-37.
91. Spratt BG. Resistance to antibiotics mediated by target alterations. Science 1994;264:388-93.
92. Antignac A, Boneca IG, Rousselle JC, Namane A, Carlier JP, Vázquez JA, et al. Correlation between alterations of the penicillin-binding protein 2 and modifications of the peptidoglycan structure in Neisseria meningitidis with reduced susceptibility to penicillin G. J Biol Chem 2003;278:31529-35.
93. Dessen A, Mouz N, Gordon E, Hopkins J, Dideberg O. Crystal structure of PBP2x from a highly penicillin-resistant Streptococcus pneumoniae clinical isolate: a mosaic framework containing 83 mutations. J Biol Chem 2001;276:45106-12.
94. Antignac A, Kriz P, Tzanakaki G, Alonso JM, Taha MK. Polymorphism of Neisseria meningitidis penA gene associated with reduced susceptibility to penicillin. J Antimicrob Chemother 2001;47:285-96.
95. Shultz TR, Tapsall JW, White PA, Ryan CS, Lyras D, Rood JI, et al. Chloramphenicol-resistant Neisseria meningitidis containing catP isolated in Australia. J Antimicrob Chemother 2003;52:856-9.
96. Galimand M, Gerbaud G, Guibourdenche M, Riou JY, Courvalin P. High-level chloramphenicol resistance in Neisseria meningitidis. N Engl J Med 1998;339:868-74.
97. Tondella ML, Rosenstein NE, Mayer LW, Tenover FC, Stocker SA, Reeves MW, et al. Lack of evidence for chloramphenicol resistance in Neisseria meningitidis, Africa. Emerg Infect Dis 2001;7:163-4.
98. Shultz TR, Tapsall JW, White PA, Newton PJ. An invasive isolate of Neisseria meningitidis showing decreased susceptibility to quinolones. Antimicrob Agents Chemother 2000;44:1116.
99. Alonso R, Galimand M, Courvalin P. An extended PCR-RFLP assay for detection of parC, parE and gyrA mutations in fluoroquinolone-resistant Streptococcus pneumoniae. J Antimicrob Chemother 2004.
100. Qvarnstrom Y, Swedberg G. Additive effects of a two-amino-acid insertion and a single-amino-acid substitution in dihydropteroate synthase for the development of sulphonamide-resistant Neisseria meningitidis. Microbiology 2000;146(Pt 5):1151-6.
101. Fermér C, Kristiansen BE, Skold O, Swedberg G. Sulfonamide resistance in Neisseria meningitidis as defined by site-directed mutagenesis could have its origin in other species. J Bacteriol 1995;177:4669-75.
102. Tokue Y, Shoji S, Satoh K, Watanabe A, Motomiya M. Comparison of a polymerase chain reaction assay and a conventional microbiologic method for detection of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1992;36:6-9.
103. Ubukata K, Nakagami S, Nitta A, Yamane A, Kawakami S, Sugiura M, et al. Rapid detection of the mecA gene in methicillin-resistant staphylococci by enzymatic detection of polymerase chain reaction products. J Clin Microbiol 1992;30:1728-33.
104. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995;33:24-7.
105. Patel R, Uhl R, Kohner P, Hopkins MK, Cockerill FR 3rd. Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci. J Clin Microbiol 1997;35:703-7.
106. Antignac A, Alonso JM, Taha MK. Nonculture prediction of Neisseria meningitidis susceptibility to penicillin. Antimicrob Agents Chemother 2001;45:3625-8.
107. Borrow R, Claus H, Chaudhry U, Guiver M, Kaczmarski EB, Frosch M, et al. siaD PCR ELISA for confirmation and identification of serogroup Y and W135 meningococcal infections. FEMS Microbiol Lett 1998;159:209-14.
108. Borrow R, Claus H, Guiver M, Smart L, Jones DM, Kaczmarski EB, et al. Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA. Epidemiol Infect 1997;118:111-7.
109. Orvelid P, Bäckman A, Olcén P. PCR identification of the group A Neisseria meningitidis gene in cerebrospinal fluid. Scand J Infect Dis 1999;31:481-3.
110. Tzeng YL, Noble C, Stephens DS. Genetic basis for biosynthesis of the (alpha 1->4)-linked N-acetyl-D-glucosamine 1-phosphate capsule of Neisseria meningitidis serogroup X. Infect Immun 2003;71:6712-20.
111. Mölling P, Unemo M, Bäckman A, Olcén P. Genosubtyping by sequencing group A, B and C meningococci; a tool for epidemiological studies of epidemics, clusters and sporadic cases. Apmis 2000;108:509-16.
112. Wedege E, Caugant DA, Musacchio A, Saunders NB, Zollinger WD. Redesignation of a purported P1.15 subtype-specific meningococcal monoclonal antibody as a P1.19-specific reagent. Clin Diagn Lab Immunol 1999;6:639-42.
113. Arhin FF, Moreau F, Coulton JW, Mills EL. Sequencing of porA from clinical isolates of Neisseria meningitidis defines a subtyping scheme and its genetic regulation. Can J Microbiol 1998;44:56-63.
114. Maiden MC, Bygraves JA, McCarvil J, Feavers IM. Identification of meningococcal serosubtypes by polymerase chain reaction. J Clin Microbiol 1992;30:2835-41.
115. van der Ende A, Hopman CT, Keijzers WC, Spanjaard L, Lodder EB, van Keulen PH, et al. Outbreak of meningococcal disease caused by PorA-deficient meningococci. J Infect Dis 2003;187:869-71.
116. Falla TJ, Crook DW, Brophy LN, Maskell D, Kroll JS, Moxon ER. PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol 1994;32:2382-6.
117. Sidikou F, Djibo S, Taha MK, Alonso JM, Djibo A, Kairo KK, et al. Polymerase Chain Reaction Assay and Bacterial Meningitis Surveillance in Remote Areas, Niger. Emerg Infect Dis 2003;9:1486-1488.
118. Issa M, Mölling P, Bäckman A, Unemo M, Sulaiman N, Olcén P. PCR of cerebrospinal fluid for diagnosis of bacterial meningitis during meningococcal epidemics; an example from Sudan. Scand J Infect Dis 2003;35:719-23.
119. Wedege E, Kuipers B, Bolstad K, van Dijken H, Froholm LO, Vermont C, et al. Antibody specificities and effect of meningococcal carriage in icelandic teenagers receiving the Norwegian serogroup B outer membrane vesicle vaccine. Infect Immun 2003;71:3775-81.
120. Martin SL, Borrow R, van der Ley P, Dawson M, Fox AJ, Cartwright KA. Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine. Vaccine 2000;18:2476-81.
121. Wedege E, Bolstad K, Wetzler LM, Guttormsen H. IgG antibody levels to meningococcal porins in patient sera: comparison of immunoblotting and ELISA measurements. J Immunol Methods 2000;244:9-15.
122. Feavers IM, Fox AJ, Gray S, Jones DM, Maiden MC. Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design. Clin Diagn Lab Immunol 1996;3:444-50.
123. Taha MK, Bichier E, Perrocheau A, Alonso JM. Circumvention of herd immunity during an outbreak of meningococcal disease could be correlated to escape mutation in the porA gene of Neisseria meningitidis. Infect Immun 2001;69:1971-3.
124. Smith JM, Smith NH, O'Rourke M, Spratt BG. How clonal are bacteria? Proc Natl Acad Sci U S A 1993;90:4384-8.
125. Maiden MC. Population genetics of a transformable bacterium: the influence of horizontal genetic exchange on the biology of Neisseria meningitidis. FEMS Microbiol Lett 1993;112:243-50.
126. Caugant DA. Population genetics and molecular epidemiology of Neisseria meningitidis. Apmis 1998;106:505-25.
127. Caugant DA, Mocca LF, Frasch CE, Froholm LO, Zollinger WD, Selander RK. Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J Bacteriol 1987;169:2781-92.
128. Achtman M, Heuzenroeder M, Kusecek B, Ochman H, Caugant D, Selander RK, et al. Clonal analysis of Escherichia coli O2:K1 isolated from diseased humans and animals. Infect Immun 1986;51:268-76.
129. Feil EJ, Maiden MC, Achtman M, Spratt BG. The relative contributions of recombination and mutation to the divergence of clones of Neisseria meningitidis. Mol Biol Evol 1999;16:1496-502.
130. Popovic T, Schmink S, Rosenstein NA, Ajello GW, Reeves MW, Plikaytis B, et al. Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. J Clin Microbiol 2001;39:75-85.
131. Fasola E, Livdahl C, Ferrieri P. Molecular analysis of multiple isolates of the major serotypes of group B streptococci. J Clin Microbiol 1993;31:2616-20.
132. Jelfs J, Munro R, Ashto FE, Caugant DA. Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world. Epidemiol Infect 2000;125:285-98.
133. Dmitriev A, Hu YY, Shen AD, Suvorov A, Yang YH. Chromosomal analysis of group B streptococcal clinical strains; bac gene-positive strains are genetically homogenous. FEMS Microbiol Lett 2002;208:93-8.
134. Rocourt J. [Taxonomy of the Listeria genus and typing of L. monocytogenes]. Pathol Biol (Paris) 1996;44:749-56.
135. Hookey JV, Edwards V, Patel S, Richardson JF, Cookson BD. Use of fluorescent amplified fragment length polymorphism (fAELP) to characterise methicillin-resistant Staphylococcus aureus. J Microbiol Methods 1999;37:7-15.
136. Keim P, Price LB, Klevytska AM, Smith KL, Schupp JM, Okinaka R, et al. Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis. J Bacteriol 2000;182:2928-36.
137. Mayer LW, Reeves MW, Al-Hamdan N, Sacchi CT, Taha MK, Ajello GW, et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J Infect Dis 2002;185:1596-605.
138. Zhang GW, Kotiw M, Daggard G. A RAPD-PCR genotyping assay which correlates with serotypes of group B streptococci. Lett Appl Microbiol 2002;35:247-50.
139. Bart A, Schuurman IG, Achtman M, Caugant DA, Dankert J, van der Ende A. Randomly amplified polymorphic DNA genotyping of serogroup A meningococci yields results similar to those obtained by multilocus enzyme electrophoresis and reveals new genotypes. J Clin Microbiol 1998;36:1746-9.
140. Sacchi CT, Whitney AM, Reeves MW, Mayer LW, Popovic T. Sequence diversity of Neisseria meningitidis 16S rRNA genes and use of 16S rRNA gene sequencing as a molecular subtyping tool. J Clin Microbiol 2002;40:4520-7.
141. Caugant DA, Levin BR, Orskov I, Ørskov F, Svanborg Eden C, Selander RK. Genetic diversity in relation to serotype in Escherichia coli. Infect Immun 1985;49:407-13.
142. Caugant DA, Levin BR, Selander RK. Distribution of multilocus genotypes of Escherichia coli within and between host families. J Hyg (Lond) 1984;92:377-84.
143. Porras O, Caugant DA, Lagergard T, Svanborg-Eden C. Application of multilocus enzyme gel electrophoresis to Haemophilus influenzae. Infect Immun 1986;53:71-8.
144. Caugant DA, Bøvre K, Gaustad P, Bryn K, Holten E, Høby EA, et al. Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers. J Gen Microbiol 1986;132 (Pt 3):641-52.
145. Selander RK, Musser JM, Caugant DA, Gilmour MN, Whittam TS. Population genetics of pathogenic bacteria. Microb Pathog 1987;3:1-7.
146. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998;95:3140-5.
147. Urwin R, Maiden MC. Multi-locus sequence typing: a tool for global epidemiology. Trends Microbiol 2003;11:479-87.
148. Giorgini D, Nassif X, Taha MK. [Rapid epidemiological characterization of Neisseria meningitidis using polymerization chain reaction from biological samplings]. Presse Med 1997;26:1516-9.
149. Kriz P, Kalmusova J, Felsberg J. Multilocus sequence typing of Neisseria meningitidis directly from cerebrospinal fluid. Epidemiol Infect 2002;128:157-60.
150. Hackett SJ, Guiver M, Marsh J, Sills JA, Thomson AP, Kaczmarski EB, et al. Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child 2002;86:44-6.
151. Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis 2000;30:122-40.
152. Kroll JS, Moxon ER, Loynds BM. An ancestral mutation enhancing the fitness and increasing the virulence of Haemophilus influenzae type b. J Infect Dis 1993;168:172-6.
153. Lipsitch M. Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci USA 1997;94:6571-6.
154. Bennett D, Lennon B, Humphreys H, Cafferkey M. Penicillin susceptibility and epidemiological typing of invasive pneumococcal isolates in the Republic of Ireland. J Clin Microbiol 2003;41:3641-8.
155. Hall LM. Application of molecular typing to the epidemiology of Streptococcus pneumoniae. J Clin Pathol 1998;51:270-4.
156. Popovic T, Sacchi CT, Reeves MW, Whitney AM, Mayer LW, Noble CA, et al. Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex. Emerg Infect Dis 2000;6:428-9.
157. Taha MK, Achtman M, Alonso JM, Greenwood B, Ramsay M, Fox A, et al. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 2000;356:2159.
158. Swartley JS, Marfin AA, Edupuganti S, Liu LJ, Cieslak P, Perkins B, et al. Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci USA 1997;94:271-6.
159. Kriz P, Giorgini D, Musilek M, Larribe M, Taha MK. Microevolution through DNA exchange among strains of Neisseria meningitidis isolated during an outbreak in the Czech Republic. Res Microbiol 1999;150:273-80.
160. Kertesz DA, Coulthart MB, Ryan JA, Johnson WM, Ashton FE. Serogroup B, electrophoretic type 15 Neisseria meningitidis in Canada. J Infect Dis 1998;177:1754-7.
161. Perez-Trallero E, Vicente D, Montes M, Cisterna R. Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis. Lancet 2002;360:953.
162. Smith I, Lehmann AK, Lie L, Digranes A, Caugant DA, Høby EA, et al. Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication. Epidemiol Infect 1999;123:373-82.
163. Bjune G, Høby EA, Gronnesby JK, Arnesen O, Fredriksen JH, Halstensen A, et al. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 1991;338:1093-6.
164. Lystad A, Aasen S. The epidemiology of meningococcal disease in Norway 1975-91. NIPH Ann 1991;14:57-65; discussion 65-6.
165. Issa M, Mölling P, Unemo M, Bäckman A, Mosaad M, Sulaiman N, et al. Neisseria meningitidis serogroup W-135 isolated from healthy carriers and patients in Sudan after the Hajj in 2000. Scand J Infect Dis 2003;35:230-3.
166. WHO. Meningococcal disease, serogroup W135, Burkina Faso: preliminary report 2002. Wkly Epidemiol Rec 2002;77:152-155.
167. Fonkoua MC, Taha MK, Nicolas P, Cunin P, Alonso JM, Bercion R, et al. Recent increase in meningitis Caused by Neisseria meningitidis serogroups A and W135, Yaounde, Cameroon. Emerg Infect Dis 2002;8:327-9.
168. Mölling P, Bäckman A, Olcén P, Fredlund H. Comparison of serogroup W-135 meningococci isolated in Sweden during a 23-year period and those associated with a recent hajj pilgrimage. J Clin Microbiol 2001;39:2695-9.
169. Taha MK, Giorgini D, Ducos-Galand M, Alonso JM. The continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease, after its emergence in 2000. J Clin Microbiol 2004;42:4158-63.
170. Hamels S, Gala JL, Dufour S, Vannuffel P, Zammatteo N, Remacle J. Consensus PCR and microarray for diagnosis of the genus Staphylococcus, species, and methicillin resistance. Biotechniques 2001;31:1364-6, 1368, 1370-2.
171. Fukushima M, Kakinuma K, Hayashi H, Nagai H, Ito K, Kawaguchi R. Detection and identification of Mycobacterium species isolates by DNA microarray. J Clin Microbiol 2003;41:2605-15.